Lucio Pallares

Palma, PM, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.

Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.

Journal: Lupus science & medicine

Published: January 22, 2026

Belimumab patient profile in Spain: evolution during the last decade and future directions.

Belimumab patient profile in Spain: evolution during the last decade and future directions.

Journal: Expert opinion on biological therapy

Published: March 13, 2025

Correction to: An online survey of the Spanish Lupus Patient Association (FELUPUS): patient perceptions and experiences.

Correction to: An online survey of the Spanish Lupus Patient Association (FELUPUS): patient perceptions and experiences.

Journal: Clinical rheumatology

Published: December 04, 2023

Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.

Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.

Journal: JAMA network open

Published: April 07, 2023

Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.

Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.

Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Published: October 27, 2022

An online survey of the Spanish Lupus Patient Association (FELUPUS): patient perceptions and experiences.

An online survey of the Spanish Lupus Patient Association (FELUPUS): patient perceptions and experiences.

Journal: Clinical rheumatology

Published: July 15, 2022

COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases.

COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases.

Journal: Frontiers in medicine

Published: November 03, 2021

Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.

Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey.

Journal: Archivos de la Sociedad Espanola de Oftalmologia

Published: October 15, 2020

Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: result of the COVID-19-GEAS patient survey

Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: result of the COVID-19-GEAS patient survey

Journal: Archivos de la Sociedad Espanola de Oftalmologia

Published: October 15, 2020

Clinical characterization and outcomes of 85 patients with neurosarcoidosis.

Clinical characterization and outcomes of 85 patients with neurosarcoidosis.

Journal: Scientific reports

Published: September 04, 2020

Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.

Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.

Journal: Clinical and experimental rheumatology

Published: June 23, 2019

Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis.

Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis.

Journal: Expert review of clinical immunology

Published: January 12, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026